Loading…
Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis
Pediatric osteomyelitis is an insidious disease that can lead to permanent sequelae, the management of which still relies on lengthy intravenous antibiotic therapy. The purpose of this study is to report and describe the clinical course and outcome of pediatric bacterial osteomyelitis in our experie...
Saved in:
Published in: | Scientific reports 2022-09, Vol.12 (1), p.14846-14846, Article 14846 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803 |
---|---|
cites | cdi_FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803 |
container_end_page | 14846 |
container_issue | 1 |
container_start_page | 14846 |
container_title | Scientific reports |
container_volume | 12 |
creator | Krzysztofiak, Andrzej Roversi, Marco Musolino, Antonio Cirillo, Marco Toniolo, Renato Maria Mazza, Osvaldo Gargiullo, Livia Lancella, Laura Rossi, Paolo Villani, Alberto |
description | Pediatric osteomyelitis is an insidious disease that can lead to permanent sequelae, the management of which still relies on lengthy intravenous antibiotic therapy. The purpose of this study is to report and describe the clinical course and outcome of pediatric bacterial osteomyelitis in our experience. We reported the clinical, diagnostic, and treatment characteristics of all cases of osteomyelitis in children younger than 18 years of age who were hospitalized between January 2010 and December 2021 at the Bambino Gesù Children’s Hospital in Rome, Italy, we compared patients with and without complications at follow-up, to identify any predictive factor for sequelae. The study sample included 319 cases of pediatric bacterial osteomyelitis. The median age was 7.77 years. Males (60.8%) were more affected than females. The most affected bones were the femur, tibia, and spine. Etiology was identified in 40.1% of cases, with
S.aureus
as the most common causative agent. Sequelae were reported in 43 cases (13.5%). The main predictors of sequelae were sepsis on admission and hypergammaglobulinemia. Our results show that a severe presentation with sepsis and hypergammaglobulinemia on admission may be associated with a higher frequency of late sequelae. Early recognition and aggressive treatment of this subgroup of patients may lead to a reduction in complications. |
doi_str_mv | 10.1038/s41598-022-19208-2 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5f35a708f89f471099151329af680f1c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_5f35a708f89f471099151329af680f1c</doaj_id><sourcerecordid>2709741034</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhhtR3GXdP-CpwYuX1spXd3IRZHB1YcGL3oRQnVSPGXo6Y5IR9t-bmV7U9WAuCamnHpLibZqXDN4wEPptlkwZ3QHnHTMcdMefNJccpOq44PzpX-eL5jrnHdSluJHMPG8uRA8KpGSXzbfNHJbgcG4THWIqLS6-PSTywZWYchunNtOPI81Ip7NgpnWY6Vw4VApLCq4d0RVKoVpiLhT39zSHEvKL5tmEc6brh_2q-Xrz4cvmU3f3-ePt5v1d5xQbSjc45Wn0ZNBI7UbmuB9hdG4gAYRKowbp_GBIMhix9wIlx74fPTBFWoO4am5Xr4-4s4cU9pjubcRgzxcxbS2mEtxMVk1C4QB60maSAwNjmGKCG5x6DRNz1fVudR2O4568o6UknB9JH1eW8N1u409rpBhA9lXw-kGQYh1cLnYfsqN5xoXiMVs-gBnqT4Ss6Kt_0F08pqWO6kRpbaA3vFJ8pVyKOSeafj-GgT1lwa5ZsDUL9pwFe2oSa1Ou8LKl9Ef9n65f-QW1mw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708890692</pqid></control><display><type>article</type><title>Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis</title><source>Publicly Available Content Database</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Krzysztofiak, Andrzej ; Roversi, Marco ; Musolino, Antonio ; Cirillo, Marco ; Toniolo, Renato Maria ; Mazza, Osvaldo ; Gargiullo, Livia ; Lancella, Laura ; Rossi, Paolo ; Villani, Alberto</creator><creatorcontrib>Krzysztofiak, Andrzej ; Roversi, Marco ; Musolino, Antonio ; Cirillo, Marco ; Toniolo, Renato Maria ; Mazza, Osvaldo ; Gargiullo, Livia ; Lancella, Laura ; Rossi, Paolo ; Villani, Alberto ; Collaborative Osteomyelitis Study Group</creatorcontrib><description>Pediatric osteomyelitis is an insidious disease that can lead to permanent sequelae, the management of which still relies on lengthy intravenous antibiotic therapy. The purpose of this study is to report and describe the clinical course and outcome of pediatric bacterial osteomyelitis in our experience. We reported the clinical, diagnostic, and treatment characteristics of all cases of osteomyelitis in children younger than 18 years of age who were hospitalized between January 2010 and December 2021 at the Bambino Gesù Children’s Hospital in Rome, Italy, we compared patients with and without complications at follow-up, to identify any predictive factor for sequelae. The study sample included 319 cases of pediatric bacterial osteomyelitis. The median age was 7.77 years. Males (60.8%) were more affected than females. The most affected bones were the femur, tibia, and spine. Etiology was identified in 40.1% of cases, with
S.aureus
as the most common causative agent. Sequelae were reported in 43 cases (13.5%). The main predictors of sequelae were sepsis on admission and hypergammaglobulinemia. Our results show that a severe presentation with sepsis and hypergammaglobulinemia on admission may be associated with a higher frequency of late sequelae. Early recognition and aggressive treatment of this subgroup of patients may lead to a reduction in complications.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-022-19208-2</identifier><identifier>PMID: 36050441</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/1537 ; 692/308 ; Bacteria ; Complications ; Etiology ; Femur ; Humanities and Social Sciences ; Hypergammaglobulinemia ; Intravenous administration ; multidisciplinary ; Osteomyelitis ; Patients ; Pediatrics ; Science ; Science (multidisciplinary) ; Sepsis ; Spine ; Tibia</subject><ispartof>Scientific reports, 2022-09, Vol.12 (1), p.14846-14846, Article 14846</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803</citedby><cites>FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2708890692/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2708890692?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids></links><search><creatorcontrib>Krzysztofiak, Andrzej</creatorcontrib><creatorcontrib>Roversi, Marco</creatorcontrib><creatorcontrib>Musolino, Antonio</creatorcontrib><creatorcontrib>Cirillo, Marco</creatorcontrib><creatorcontrib>Toniolo, Renato Maria</creatorcontrib><creatorcontrib>Mazza, Osvaldo</creatorcontrib><creatorcontrib>Gargiullo, Livia</creatorcontrib><creatorcontrib>Lancella, Laura</creatorcontrib><creatorcontrib>Rossi, Paolo</creatorcontrib><creatorcontrib>Villani, Alberto</creatorcontrib><creatorcontrib>Collaborative Osteomyelitis Study Group</creatorcontrib><title>Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><description>Pediatric osteomyelitis is an insidious disease that can lead to permanent sequelae, the management of which still relies on lengthy intravenous antibiotic therapy. The purpose of this study is to report and describe the clinical course and outcome of pediatric bacterial osteomyelitis in our experience. We reported the clinical, diagnostic, and treatment characteristics of all cases of osteomyelitis in children younger than 18 years of age who were hospitalized between January 2010 and December 2021 at the Bambino Gesù Children’s Hospital in Rome, Italy, we compared patients with and without complications at follow-up, to identify any predictive factor for sequelae. The study sample included 319 cases of pediatric bacterial osteomyelitis. The median age was 7.77 years. Males (60.8%) were more affected than females. The most affected bones were the femur, tibia, and spine. Etiology was identified in 40.1% of cases, with
S.aureus
as the most common causative agent. Sequelae were reported in 43 cases (13.5%). The main predictors of sequelae were sepsis on admission and hypergammaglobulinemia. Our results show that a severe presentation with sepsis and hypergammaglobulinemia on admission may be associated with a higher frequency of late sequelae. Early recognition and aggressive treatment of this subgroup of patients may lead to a reduction in complications.</description><subject>692/1537</subject><subject>692/308</subject><subject>Bacteria</subject><subject>Complications</subject><subject>Etiology</subject><subject>Femur</subject><subject>Humanities and Social Sciences</subject><subject>Hypergammaglobulinemia</subject><subject>Intravenous administration</subject><subject>multidisciplinary</subject><subject>Osteomyelitis</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Sepsis</subject><subject>Spine</subject><subject>Tibia</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk2LFDEQhhtR3GXdP-CpwYuX1spXd3IRZHB1YcGL3oRQnVSPGXo6Y5IR9t-bmV7U9WAuCamnHpLibZqXDN4wEPptlkwZ3QHnHTMcdMefNJccpOq44PzpX-eL5jrnHdSluJHMPG8uRA8KpGSXzbfNHJbgcG4THWIqLS6-PSTywZWYchunNtOPI81Ip7NgpnWY6Vw4VApLCq4d0RVKoVpiLhT39zSHEvKL5tmEc6brh_2q-Xrz4cvmU3f3-ePt5v1d5xQbSjc45Wn0ZNBI7UbmuB9hdG4gAYRKowbp_GBIMhix9wIlx74fPTBFWoO4am5Xr4-4s4cU9pjubcRgzxcxbS2mEtxMVk1C4QB60maSAwNjmGKCG5x6DRNz1fVudR2O4568o6UknB9JH1eW8N1u409rpBhA9lXw-kGQYh1cLnYfsqN5xoXiMVs-gBnqT4Ss6Kt_0F08pqWO6kRpbaA3vFJ8pVyKOSeafj-GgT1lwa5ZsDUL9pwFe2oSa1Ou8LKl9Ef9n65f-QW1mw</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Krzysztofiak, Andrzej</creator><creator>Roversi, Marco</creator><creator>Musolino, Antonio</creator><creator>Cirillo, Marco</creator><creator>Toniolo, Renato Maria</creator><creator>Mazza, Osvaldo</creator><creator>Gargiullo, Livia</creator><creator>Lancella, Laura</creator><creator>Rossi, Paolo</creator><creator>Villani, Alberto</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220901</creationdate><title>Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis</title><author>Krzysztofiak, Andrzej ; Roversi, Marco ; Musolino, Antonio ; Cirillo, Marco ; Toniolo, Renato Maria ; Mazza, Osvaldo ; Gargiullo, Livia ; Lancella, Laura ; Rossi, Paolo ; Villani, Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>692/1537</topic><topic>692/308</topic><topic>Bacteria</topic><topic>Complications</topic><topic>Etiology</topic><topic>Femur</topic><topic>Humanities and Social Sciences</topic><topic>Hypergammaglobulinemia</topic><topic>Intravenous administration</topic><topic>multidisciplinary</topic><topic>Osteomyelitis</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Sepsis</topic><topic>Spine</topic><topic>Tibia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krzysztofiak, Andrzej</creatorcontrib><creatorcontrib>Roversi, Marco</creatorcontrib><creatorcontrib>Musolino, Antonio</creatorcontrib><creatorcontrib>Cirillo, Marco</creatorcontrib><creatorcontrib>Toniolo, Renato Maria</creatorcontrib><creatorcontrib>Mazza, Osvaldo</creatorcontrib><creatorcontrib>Gargiullo, Livia</creatorcontrib><creatorcontrib>Lancella, Laura</creatorcontrib><creatorcontrib>Rossi, Paolo</creatorcontrib><creatorcontrib>Villani, Alberto</creatorcontrib><creatorcontrib>Collaborative Osteomyelitis Study Group</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krzysztofiak, Andrzej</au><au>Roversi, Marco</au><au>Musolino, Antonio</au><au>Cirillo, Marco</au><au>Toniolo, Renato Maria</au><au>Mazza, Osvaldo</au><au>Gargiullo, Livia</au><au>Lancella, Laura</au><au>Rossi, Paolo</au><au>Villani, Alberto</au><aucorp>Collaborative Osteomyelitis Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><date>2022-09-01</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>14846</spage><epage>14846</epage><pages>14846-14846</pages><artnum>14846</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Pediatric osteomyelitis is an insidious disease that can lead to permanent sequelae, the management of which still relies on lengthy intravenous antibiotic therapy. The purpose of this study is to report and describe the clinical course and outcome of pediatric bacterial osteomyelitis in our experience. We reported the clinical, diagnostic, and treatment characteristics of all cases of osteomyelitis in children younger than 18 years of age who were hospitalized between January 2010 and December 2021 at the Bambino Gesù Children’s Hospital in Rome, Italy, we compared patients with and without complications at follow-up, to identify any predictive factor for sequelae. The study sample included 319 cases of pediatric bacterial osteomyelitis. The median age was 7.77 years. Males (60.8%) were more affected than females. The most affected bones were the femur, tibia, and spine. Etiology was identified in 40.1% of cases, with
S.aureus
as the most common causative agent. Sequelae were reported in 43 cases (13.5%). The main predictors of sequelae were sepsis on admission and hypergammaglobulinemia. Our results show that a severe presentation with sepsis and hypergammaglobulinemia on admission may be associated with a higher frequency of late sequelae. Early recognition and aggressive treatment of this subgroup of patients may lead to a reduction in complications.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36050441</pmid><doi>10.1038/s41598-022-19208-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2022-09, Vol.12 (1), p.14846-14846, Article 14846 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_5f35a708f89f471099151329af680f1c |
source | Publicly Available Content Database; Full-Text Journals in Chemistry (Open access); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 692/1537 692/308 Bacteria Complications Etiology Femur Humanities and Social Sciences Hypergammaglobulinemia Intravenous administration multidisciplinary Osteomyelitis Patients Pediatrics Science Science (multidisciplinary) Sepsis Spine Tibia |
title | Clinical report and predictors of sequelae of 319 cases of pediatric bacterial osteomyelitis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T10%3A12%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20report%20and%20predictors%20of%20sequelae%20of%20319%20cases%20of%20pediatric%20bacterial%20osteomyelitis&rft.jtitle=Scientific%20reports&rft.au=Krzysztofiak,%20Andrzej&rft.aucorp=Collaborative%20Osteomyelitis%20Study%20Group&rft.date=2022-09-01&rft.volume=12&rft.issue=1&rft.spage=14846&rft.epage=14846&rft.pages=14846-14846&rft.artnum=14846&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-022-19208-2&rft_dat=%3Cproquest_doaj_%3E2709741034%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c517t-7c5debde9a948cb1c2db0bcc7e30ea58a804cd79e410ba6d3a42a66bd015e8803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2708890692&rft_id=info:pmid/36050441&rfr_iscdi=true |